1
|
Lee CC, Liao YC, Lai YH, Lee CCD, Chuang MC. Recognition of dual targets by a molecular beacon-based sensor: subtyping of influenza A virus. Anal Chem 2015; 87:5410-6. [PMID: 25879394 DOI: 10.1021/acs.analchem.5b00810] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
A molecular beacon (MB)-based sensor to offer a decisive answer in combination with information originated from dual-target inputs is designed. The system harnesses an assistant strand and thermodynamically favored designation of unpaired nucleotides (UNs) to process the binary targets in "AND-gate" format and report fluorescence in "off-on" mechanism via a formation of a DNA four-way junction (4WJ). By manipulating composition of the UNs, the dynamic fluorescence difference between the binary targets-coexisting circumstance and any other scenario was maximized. Characteristic equilibrium constant (K), change of entropy (ΔS), and association rate constant (k) between the association ("on") and dissociation ("off") states of the 4WJ were evaluated to understand unfolding behavior of MB in connection to its sensing capability. Favorable MB and UNs were furthermore designed toward analysis of genuine genetic sequences of hemagglutinin (HA) and neuraminidase (NA) in an influenza A H5N2 isolate. The MB-based sensor was demonstrated to yield a linear calibration range from 1.2 to 240 nM and detection limit of 120 pM. Furthermore, high-fidelity subtyping of influenza virus was implemented in a sample of unpurified amplicons. The strategy opens an alternative avenue of MB-based sensors for dual targets toward applications in clinical diagnosis.
Collapse
Affiliation(s)
- Chun-Ching Lee
- †Department of Chemistry, Tunghai University, Taichung 40704, Taiwan
| | - Yu-Chieh Liao
- ‡Institute of Population Health Science, National Health Research Institutes, Zhunan, Miaoli County 35053, Taiwan
| | - Yu-Hsuan Lai
- †Department of Chemistry, Tunghai University, Taichung 40704, Taiwan
| | | | - Min-Chieh Chuang
- †Department of Chemistry, Tunghai University, Taichung 40704, Taiwan
| |
Collapse
|
3
|
Yu H, Huang J, Huai Y, Guan X, Klena J, Liu S, Peng Y, Yang H, Luo J, Zheng J, Chen M, Peng Z, Xiang N, Huo X, Xiao L, Jiang H, Chen H, Zhang Y, Xing X, Xu Z, Feng Z, Zhan F, Yang W, Uyeki TM, Wang Y, Varma JK. The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010-2012. Influenza Other Respir Viruses 2014; 8:53-65. [PMID: 24209711 PMCID: PMC4177798 DOI: 10.1111/irv.12205] [Citation(s) in RCA: 66] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/26/2013] [Indexed: 11/28/2022] Open
Abstract
BACKGROUND Published data on influenza in severe acute respiratory infection (SARI) patients are limited. We conducted SARI surveillance in central China and estimated hospitalization rates of SARI attributable to influenza by viral type/subtype. METHODS Surveillance was conducted at four hospitals in Jingzhou, China from 2010 to 2012. We enrolled hospitalized patients who had temperature ≥37·3°C and at least one of: cough, sore throat, tachypnea, difficulty breathing, abnormal breath sounds on auscultation, sputum production, hemoptysis, chest pain, or chest radiograph consistent with pneumonia. A nasopharyngeal swab was collected from each case-patient within 24 hours of admission for influenza testing by real-time reverse transcription PCR. RESULTS Of 17 172 SARI patients enrolled, 90% were aged <15 years. The median duration of hospitalization was 5 days. Of 16 208 (94%) SARI cases tested, 2057 (13%) had confirmed influenza, including 1427 (69%) aged <5 years. Multiple peaks of influenza occurred during summer, winter, and spring months. Influenza was associated with an estimated 115 and 142 SARI hospitalizations per 100 000 during 2010-2011 and 2011-2012 [including A(H3N2): 55 and 44 SARI hospitalizations per 100 000; pandemic A(H1N1): 33 SARI hospitalizations per 100 000 during 2010-2011; influenza B: 26 and 98 hospitalizations per 100 000], with the highest rate among children aged 6-11 months (3603 and 3805 hospitalizations per 100 000 during 2010-2011 and 2011-2012, respectively). CONCLUSIONS In central China, influenza A and B caused a substantial number of hospitalizations during multiple periods each year. Our findings strongly suggest that young children should be the highest priority group for annual influenza vaccination in China.
Collapse
Affiliation(s)
- Hongjie Yu
- Divison of Infectious Disease, Chinese Center for Disease Control and PreventionBeijing, China
| | - Jigui Huang
- Jingzhou Center for Disease Control and PreventionJingzhou, China
| | - Yang Huai
- China-US Collaborative Program on Emerging and Re-emerging Infection Disease, US Centers for Disease Control and PreventionBeijing, China
| | - Xuhua Guan
- Hubei Provincial Centre for Disease Control and PreventionWuhan, China
| | - John Klena
- China-US Collaborative Program on Emerging and Re-emerging Infection Disease, US Centers for Disease Control and PreventionBeijing, China
| | - Shali Liu
- Jingzhou Central HospitalJingzhou, China
| | | | - Hui Yang
- Jingzhou Second People's HospitalJingzhou, China
| | - Jun Luo
- Jingzhou Maternal and Children's HospitalJingzhou, China
| | - Jiandong Zheng
- Divison of Infectious Disease, Chinese Center for Disease Control and PreventionBeijing, China
| | - Maoyi Chen
- Jingzhou Center for Disease Control and PreventionJingzhou, China
| | - Zhibin Peng
- Divison of Infectious Disease, Chinese Center for Disease Control and PreventionBeijing, China
| | - Nijuan Xiang
- Public Health Emergency Center, Chinese Center for Disease Control and PreventionBeijing, China
| | - Xixiang Huo
- Hubei Provincial Centre for Disease Control and PreventionWuhan, China
| | - Lin Xiao
- Jingzhou Center for Disease Control and PreventionJingzhou, China
| | - Hui Jiang
- Divison of Infectious Disease, Chinese Center for Disease Control and PreventionBeijing, China
| | - Hui Chen
- Hubei Provincial Centre for Disease Control and PreventionWuhan, China
| | - Yuzhi Zhang
- China-US Collaborative Program on Emerging and Re-emerging Infection Disease, US Centers for Disease Control and PreventionBeijing, China
| | - Xuesen Xing
- Hubei Provincial Centre for Disease Control and PreventionWuhan, China
| | - Zhen Xu
- Divison of Infectious Disease, Chinese Center for Disease Control and PreventionBeijing, China
| | - Zijian Feng
- Public Health Emergency Center, Chinese Center for Disease Control and PreventionBeijing, China
| | - Faxian Zhan
- Hubei Provincial Centre for Disease Control and PreventionWuhan, China
| | - Weizhong Yang
- Chinese Center for Disease Control and PreventionBeijing, China
| | - Timothy M Uyeki
- Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and PreventionAtlanta, GA, USA
| | - Yu Wang
- Chinese Center for Disease Control and PreventionBeijing, China
| | - Jay K Varma
- China-US Collaborative Program on Emerging and Re-emerging Infection Disease, US Centers for Disease Control and PreventionBeijing, China
- Global Disease Detection Program, Division of Global Disease Detection and Response, Center for Global Health, Centers for Disease Control and PreventionAtlanta, GA, USA
| |
Collapse
|